Journals / Eurasian Journal of Medicine / 2017 / Cilt: 49 - Sayı: 2

Çocuk Yoğun Bakım Ünitesinde Ventilatör İlişkili Pnömoniye Neden Olan Mikroorganizmaların Değerlendirilmesi

Evaluation of Microorganisms Causing Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit

Pages
87–91
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In VAP, it is essential to catalog antibiotic resistance patterns of bacteria present in the unit to ensure that empirical antibiotic therapy is effective

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to identify microorganisms causing ventilator-associated pneumonia (VAP) and also study the antibiotic resistance/susceptibility.
📊
Key Findings & Data:Materials and Methods: We retrospectively assessed microorganisms isolated from patients diagnosed with VAP in a pediatric intensive care unit between January 1, 2014, and June 30, 2016.
💡
Conclusion & Impact:Conclusion: In VAP, it is essential to catalog antibiotic resistance patterns of bacteria present in the unit to ensure that empirical antibiotic therapy is effective
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to identify microorganisms causing ventilator-associated pneumonia (VAP) and also study the antibiotic resistance/susceptibility. Materials and Methods: We retrospectively assessed microorganisms isolated from patients diagnosed with VAP in a pediatric intensive care unit between January 1, 2014, and June 30, 2016. Results: We included 44 patients diagnosed with VAP. The prevalence thereof was 8.6 patients per 1,000 ventilator days. Mechanical ventilation was required for 56.5% of patients. Thirty-three patients (75%) died. An underlying chronic disease was detected in 75% of patients (n=33). Fifty microorganisms were isolated from 44 patients. Single microorganisms were isolated from 86.4% (n=38) and two from 13.6% (n=6) of patients. Of all the isolated bacteria, 96% (n=48) were gram-negative; the most common was Pseudomonas aeruginosa (32%), followed by Klebsiella pneumoniae (24%) and Acinetobacter baumannii (22%). The isolates were most susceptible to colistin (92.6%), followed by piperacillin-tazobactam (71.4%), amikacin (65.2%), and gentamicin (52.2%). No enterobacterium or Acinetobacter strain was resistant to colistin; however, 13% of P. aeruginosa isolates were resistant. Conclusion: In VAP, it is essential to catalog antibiotic resistance patterns of bacteria present in the unit to ensure that empirical antibiotic therapy is effective

Özet

Amaç: Bu çalışmanın amacı ventilatör ilişkili pnömoniye (VIP) neden olan mikroorganizmaların belirlenmesidir. Ayrıca antibiyotik duyarlılık ve direnç oranları belirlenmiştir.Gereç ve Yöntem: Çocuk yoğun bakım ünitesinde, 1 Ocak 2014-30 Haziran 2016 tarihleri arasında VİP tanısı alan hastalar retrospektif olarak değerlendirilmiştir. Bulgular: Çalışmaya VİP tanısı alan 44 hasta alındı. VİP hızı 1000 ventilatör gününde 8,6 olarak saptandı. Mekanik ventilatör kullanım oranı %56,5 idi. VİP tanısı alan olguların %75 (n=33)'nin öldüğü saptandı. VİP tanısı alan hastaların %75 (n=33)'inde altta yatan kronik hastalık tespit edildi. VİP tespit edilen 44 olguda 50 mikroorganizma izole edildi. Olguların %86,4'nda (n=38) tek mikroorganizma, %13.6 (n=6)'nda iki mikroorganizma etken olarak izole edildi. İzole edilen suşların %96'sının (n=48) gram negatif bakteri olduğu saptandı. Çalışmamızda en sık izole edilen gram negatif ajan Pseudomonas Aeruginosa (%32) iken bunu Klebsiella pneumonia (%24) ve Acinetobacter baumannii (%22) izlemekte idi. Genel antibiyotik duyarlılığı incelendiğinde mikroorganizmaların en hassas olduğu antibiyotikler sırasıyla Kolistin (%92,6), Piperasilin-tazobaktam (% 71,4), Amikasin (%65,2) ve Gentamisin (%52,2) olarak saptandı. Enterobacteriaceae ve Acinetobacter suşlarında Kolistin direnci görülmezken P. aeruginosa izolatlarında, kolistin direnci %13 olarak saptandı. Sonuç: Ventilatör ilişkili pnömonidee, etkili ampirik antibiyotik tedavisi için her ünitenin kendi florasının direnç özelliklerini bilmesi gerekmektedir

🔖

Cite This Article

OZCAN, A., CETİN, S., BOZDEMİR, S. E., TORUN, Y. A., ALTUG, U., ALTİNTOP, Y. A., SAMSA, H., ERGUL, A. B. (2022). Çocuk Yoğun Bakım Ünitesinde Ventilatör İlişkili Pnömoniye Neden Olan Mikroorganizmaların Değerlendirilmesi. Eurasian Journal of Medicine, Cilt: 49 - Sayı: 2, 87–91. https://ajindex.com/articles/508992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bigham MT, Amato R, Bondurrant P, et al. Ventilatorassociated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution. J Pediatr 2009; 154: 582-7
  2. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European cooperative group on nosocomial pneumonia. Intensive Care Med 1993; 19: 256-64
  3. Galal YS, Youssef MR, Ibrahiem SK. Ventilatorassociated pneumonia: ıncidence, risk factors and outcome in paediatric ıntensive care units at Cairo University Hospital. J Clin Diagn Res 2016; 10: 6-11
  4. Magill SS, Li Q, Gross C, Dudeck M, Allen-Bridson K, Edwards JR. Incidence and characteristics of ventilator-associated events reported to the National Healthcare Safety Network in 2014. Crit Care Med 2016; 44: 2154-62
  5. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32
  6. Clinical and Laboratory Standards Institute (CLSI). Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline Third Edition. CLSI document M23-A3 (ISBN 1-56238-680-8)
  7. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008; 36: 609-26
  8. Şardan Y, Oku F, Batir E, Kabasakal E, Doluküp İ, Kösekahya A. Ulusal hastane enfeksiyonları surveyans ağı özet raporu 2015. Sağlık Bakanlığı veri raporu. 2016, 1: 17-20
  9. Şevketoğlu E, Durdu B, Açıkgoz O, Gunay L, Bulgur A, Hatipoglu S. Device-associated nosocomial infection surveillance in a Turkish pediatric intensive care unit. Türk Pediatri Ars 2010; 45: 13-7
  10. Oruc Y, Yasar N, Kara A, et al. Comparison of Healthcare-related Infection Rates Based on the National Nosocomial Infections Surveillance System of Turkey Diagnostic Criteria Reported in 2010 and Centers for Disease Control and Prevention Reported in 2014 in A Tertiary Hospital. Pediatr Inf 2016; 10: 6-9
  11. Pena-López Y, Pujol M, Campins M, et al. Implementing a care bundle approach reduces ventilator-associated pneumonia and delays ventilatorassociated tracheobronchitis in children: differences according to endotracheal or tracheostomy devices. Int J Infect Dis 2016; 52: 43-8